Ignite Creation Date:
2025-12-25 @ 4:57 AM
Ignite Modification Date:
2026-03-01 @ 9:32 AM
Study NCT ID:
NCT00990418
Status:
COMPLETED
Last Update Posted:
2010-04-27
First Post:
2009-10-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bioequivalence Between Integrated E-TRANS (Fentanyl) System and Separated (Two-Part) E-TRANS (Fentanyl) System
Sponsor:
Alza Corporation, DE, USA
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CR013654
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Senior Director
Old Organization:
Johnson & Johnson Pharmaceutical Research and Development, L.L.C.